3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
12
Pancreatic Neoplasms
6
Neoplasms
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Leukemia, Myeloid, Acute
5
Head and Neck Neoplasms
5
Urinary Bladder Neoplasms
4
Multiple Myeloma
4
Lung Neoplasms
4
Leukemia
4
Colorectal Neoplasms
4
Recurrence
3
Neoplasms, Plasma Cell
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Rectal Neoplasms
2
Radiodermatitis
2
Neoplasms by Site
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Melanoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Communication
2
Carcinoma, Transitional Cell
2
Anatomic Stage I Breast Cancer AJCC v8
2
Uterine Cervical Neoplasms
1
Urologic Neoplasms
1
Interventions
Nivolumab
11
Ipilimumab
6
linrodostat
4
relatlimab
3
Pemetrexed
2
tislelizumab
1
regorafenib
1
ralimetinib
1
p38 Mitogen-Activated Protein Kinases
1
mirdametinib
1
gedatolisib
1
figitumumab
1
efatutazone
1
abemaciclib
1
Vorinostat
1
Tetanus Toxoid
1
Tamoxifen
1
Sunitinib
1
Ranitidine
1
Midazolam
1
LY2603618
1
LY2584702
1
Irinotecan
1
Gemcitabine
1
Fulvestrant
1
Dasatinib
1
Cyclophosphamide
1
Crizotinib
1
Cetuximab
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Advanced Cancer
×
Standard of Care
×
Clear all
No trials found.